Sign up to save your podcasts
Or
Share Innovations in Oncology: Melanoma Immunotherapy, T-DM1 Advances, and Financial Access Challenges
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Innovations in Oncology: Melanoma Immunotherapy, T-DM1 Advances, and Financial Access Challenges
Love what you hear? Download the Curie app from the App Store today.
Curie is your personalized, expert-driven healthcare podcast platform—offering in-depth analysis, timely insights, and discussions tailored for medical professionals.
In this episode of Curie, Matt explores the latest breakthroughs and challenges in oncology care. Learn about novel immunotherapy combinations offering new hope for advanced melanoma patients. Dive into long-term findings solidifying trastuzumab emtansine (T-DM1) as the gold standard for certain HER2-positive breast cancer cases. Finally, discover how financial barriers are impacting patients’ access to life-saving cancer treatments—and what oncologists can do about it. Stay informed and inspired with these essential updates!
View all episodes
By Curie: The Platform for HCPsLove what you hear? Download the Curie app from the App Store today.
Curie is your personalized, expert-driven healthcare podcast platform—offering in-depth analysis, timely insights, and discussions tailored for medical professionals.
In this episode of Curie, Matt explores the latest breakthroughs and challenges in oncology care. Learn about novel immunotherapy combinations offering new hope for advanced melanoma patients. Dive into long-term findings solidifying trastuzumab emtansine (T-DM1) as the gold standard for certain HER2-positive breast cancer cases. Finally, discover how financial barriers are impacting patients’ access to life-saving cancer treatments—and what oncologists can do about it. Stay informed and inspired with these essential updates!